Diary, Homepage Posts, Newsletter

Trade Alert – (FCX) – BUY

Posted on by april@madhedgefundtrader.com
26
Sep

Trade Alert – (FCX) – BUY BUY the Freeport McMoRan (FCX) January 2027 $35-$38 out-of-the-money vertical Bull Call spread LEAPS at $1.50 or best Opening Trade 9-26-2025 expiration date: January 15, 2027 Number of Contracts = 1 contract There is nothing like adding a LEAPS on a day when the stock is down 15.8%. That […]

Continue reading →
Biotech Letter

Why This Biotech Owns The Aging Population Trade

Posted on by april@madhedgefundtrader.com

Walking through the oncology ward at Cedars-Sinai last week, I noticed something interesting. The pharmacy techs were wheeling around more Amgen (AMGN) products than I’d seen in months. Repatha for cholesterol management, EVENITY for osteoporosis, and their expanding biosimilars portfolio. It got me thinking about why Wall Street keeps sleeping on this biotech behemoth. It’s […]

Continue reading →
Diary, Homepage Posts, Newsletter

This is Not Your Father’s Nuclear Power Plant.

Posted on by april@madhedgefundtrader.com
25
Sep

With uranium prices (yellow cake) hitting a new all-time high, there is a strong message here that investors can’t ignore A nuclear renaissance is underway. Building on my early career at the Atomic Energy Commission in the 1970s, I have been covering new nuclear since 2010, and it has been a long and winding road. […]

Continue reading →
Mad Hedge AI

THE PUPPET MASTER

Posted on by Douglas Davenport
24
Sep

(TSMC), (MSFT), (NBIS), (GOOGL), (SSNLF), (INTC) There’s a phone call that happens every month between Cupertino, Seattle, and a modest office building in Hsinchu, Taiwan that determines more about the future of artificial intelligence than all the flashy product launches and CEO tweets combined.  Most investors have never heard of this conversation, but the numbers […]

Continue reading →